As of Mar 16
| +0.09 / +3.10%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 4.26, with a high estimate of 4.26 and a low estimate of 4.26. The median estimate represents a +42.45% increase from the last price of 2.99.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.